Sakai et al., Regul Pept 1991
:
The VIP induced increase in CBF was abolished by pretreatment of cells with [ 4-Cl-D-Phe6, Leu17 ] -VIP, a VIP receptor antagonist
Wilson et al., Circ Res 1981
(Anoxia...) :
These data are consistent with the possibility that local release of VIP from perivascular nerve endings could affect CBF Feliciano et al., Cardiovasc Res 1998
:
Exogenous VIP , in doses of 9.0 x 10 ( -11 ) to 2.1 x 10 ( -9 ) mol, increased CBF by 106 +/- 17 % to 169 +/- 17 % ( all p < 0.01 vs control )